Synthetic Blood International, Inc.
Name change to Oxygen Biotherapeutics, Inc.
<b>Press releases archived for reference only.</b>
Costa Mesa
California
United States
30 articles about Synthetic Blood International, Inc.
-
Synthetic Blood International, Inc. Changes Name to Oxygen Biotherapeutics, Inc.
7/1/2008
-
Synthetic Blood International, Inc. Shareholders Approve Name Change and Reincorporation
6/18/2008
-
Synthetic Blood International, Inc. Acquires Exclusive License to Use New Virginia Commonwealth University Intellectual Property
5/23/2008
-
Synthetic Blood International, Inc. Provides Updates On Phase II-B Clinical Trial Of Oxycyte; Additional Data Submitted End Of May
5/19/2008
-
Synthetic Blood International, Inc. to Open New Research Office at Virginia BioTechnology Research Park
5/7/2008
-
Synthetic Blood International, Inc. Comments on JAMA Article About Hemoglobin-Based Blood Substitutes
4/29/2008
-
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
4/22/2008
-
Synthetic Blood International, Inc. Announces Filing of Protocol for Phase II-b Oxycyte Clinical Trial
4/14/2008
-
Synthetic Blood International, Inc. Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial
4/4/2008
-
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
3/31/2008
-
Synthetic Blood International, Inc. Expands Board of Directors
3/28/2008
-
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
3/25/2008
-
Synthetic Blood International, Inc. Release: Oxycyte(R) Treatment for Traumatic Brain Injury Featured in Miami Herald Article
3/18/2008
-
Office of Naval Research Provides $3.5 Million in New Grants for Clinical Research Involving Synthetic Blood International, Inc.l's Oxycyte(R)
3/7/2008
-
Synthetic Blood International, Inc. Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
2/26/2008
-
Synthetic Blood International, Inc. Announces Medical Advisory Board Meeting Results, New Additions to Board
2/8/2008
-
Synthetic Blood International, Inc. Expands Scientific Advisory Board
1/7/2008
-
Synthetic Blood International, Inc. Announces Oxycyte Development Strategy
12/17/2007
-
Synthetic Blood International, Inc. Announces Progress with Oxycyte Program in Traumatic Brain Injury
12/11/2007
-
Synthetic Blood International, Inc. Announces VCURES Receives $1.3 Million From U.S. Navy for Decompression Sickness Research with Oxycyte
11/28/2007